Millions of Americans Ration Medications
Jake Johnson for Common Dreams
The world’s ten largest pharmaceutical giants reaped around $300 billion in combined global revenue during the first half of 2026 as millions of people in the US—the country with the highest drug prices in the world—stretched, skipped, or rationed doses to afford their medications, despite Donald Trump’s lofty pledges to slash costs.
An analysis released Thursday by the advocacy group
Protect Our Care estimates that Johnson & Johnson, Novartis, AbbVie, Merck,
Pfizer, and other pharma behemoths collectively reported $298 billion in
revenue in the first half of the year—a $24 billion increase compared to
2025—and distributed $63 billion in benefits to shareholders in the form of
share repurchases and dividends.









.webp)











